Article Details
Retrieved on: 2022-01-20 17:11:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The humanised monoclonal antibody, ALZ-201, has the potential to be developed as a novel therapy to specifically target toxic forms of the amyloid ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here